Physician profile
Nathaniel H Wright
NPI 1548672868
$2,629.16
in general payments reported to CMS, 2019-2025
15 companies · $322 in 2025
The $322 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $273 · 2020: $268 · 2021: $558 · 2022: $389 · 2023: $368 · 2024: $451 · 2025: $322.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,140.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,140.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $1,052.88 | 2019-2024 | Xarelto |
| Pfizer INC. | $505.52 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $199.46 | 2019-2025 | Eliquis, Camzyos |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $191.72 | 2023-2025 | Xifaxan |
| Abbvie INC. | $166.37 | 2021-2025 | Avycaz, Teflaro |
| Merck Sharp & Dohme LLC | $125.94 | 2022-2024 | Dificid, Zerbaxa |
| Boehringer Ingelheim Pharmaceuticals, INC. | $103.72 | 2022-2025 | Jardiance, Spiriva Respimat |
| Astrazeneca Pharmaceuticals Lp | $91.76 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $67.72 | 2019 | |
| Mallinckrodt Hospital Products INC. | $25.91 | 2023 | Terlivaz |
| Philips North America LLC | $24.19 | 2024 | (Cm9) Amb Mon & Diag Und |
| Amgen INC. | $21.10 | 2024 | Prolia, Evenity |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $20.83 | 2025 | Lifevest |
| Medtronic, INC. | $16.38 | 2023 | Intellis Adaptivestim |
| Avanir Pharmaceuticals, INC. | $15.66 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nathaniel Wright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.